Advances in the identification and management of severe epilepsy syndromes of early childhood: focus on SCN1A.
Douglass
Laurie M
LM
Boston University School of Medicine and the Boston Medical Center, Boston, Massachusetts 02118, USA. Laurie.Douglass@bmc.org
D001921:Brain / Q000254:growth & development / Q000503:physiopathology*; D002675:Child, Preschool; D042241:Early Diagnosis; D004569:Electroencephalography / Q000379:methods; D004827:Epilepsy / Q000175:diagnosis* / Q000235:genetics* / Q000628:therapy; D006580:Genetic Carrier Screening; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D006801:Humans; D007223:Infant; D062550:NAV1.1 Voltage-Gated Sodium Channel; D009419:Nerve Tissue Proteins / Q000235:genetics*; D015222:Sodium Channels / Q000235:genetics*; D013577:Syndrome
D062550:NAV1.1 Voltage-Gated Sodium Channel; D009419:Nerve Tissue Proteins; C568242:SCN1A protein, human; D015222:Sodium Channels